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Linkage to HIV care before and after the introduction of provider-initiated testing 
and counselling in six Rwandan health facilities 
Abstract 
HIV testing and counselling forms the gateway to the HIV care and treatment continuum. 
Therefore, the World Health Organization recommends provider-initiated testing and 
counselling (PITC) in countries with a generalized HIV epidemic. Few studies have investigated 
linkage-to-HIV-care among out-patients after PITC. Our objective was to study timely linkage-
to-HIV-care in six Rwandan health facilities before and after the introduction of PITC in the 
out-patient departments (OPDs). Information from patients diagnosed with HIV was abstracted 
from VCT, OPD and laboratory registers of six Rwandan health facilities during 3-month 
periods before (March-May 2009) and after (December 2009-February 2010) the introduction of 
PITC in the OPDs of these facilities. Information on patients’ subsequent linkage-to-pre-
antiretroviral treatment (ART) care and ART was abstracted from ART clinic registers of each 
health facility. To triangulate the findings from health facility routine, a survey was held among 
patients to assess reasons for non-enrolment. Of 635 patients with an HIV diagnosis, 232 
(36.5%) enrolled at the ART clinic within 90 days of diagnosis. Enrolment among out-patients 
decreased after the introduction of PITC, (adjusted odds ratio, 2.0; 95% confidence interval, 1.0-
4.2; p=0.051). Survey findings showed that retesting for HIV among patients already diagnosed 
and enrolled into care was not uncommon. Patients reported non-acceptance of disease status, 
stigma, and problems with healthcare services as main barriers for enrolment. Timely linkage-
to-HIV-care was suboptimal in this Rwandan study before and after the introduction of PITC; 
the introduction of PITC in the OPD may have had a negative impact on linkage-to-HIV-care. 
Healthier patients tested through PITC might be less ready to engage in HIV care. Fear of HIV 
stigma and mistrust of test results appear to be at the root of these problems.  
 
Key words: HIV, Continuity of Patient Care, Antiretroviral therapy, Mass Screening, Africa 
South of the Sahara, Rwanda. 
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Introduction 
The increase in access to antiretroviral therapy (ART) in sub-Sahara Africa (SSA) is a 
success story in the history of the HIV epidemic (World Health Organization (WHO), 
2013). ART has proven effective in reducing mortality rates among people infected with 
HIV (Palella et al., 1998), as well as reducing vertical (De Cock et al., 2000; Siegfried 
et al., 2011) and horizontal transmission rates (Cohen et al., 2011). Therefore, WHO 
recommends provider-initiated testing and counselling (PITC) in countries with an HIV 
prevalence of 3.0% or higher (WHO, 2007). HIV testing and counselling forms the 
gateway to the care and treatment continuum (McNairy & El Sadr, 2012). However, 
only one-third to two-thirds of patients with a new HIV diagnosis are tested for CD4 or 
return for results within 3 months of the HIV test in SSA (Kranzer et al., 2012; Rosen & 
Fox, 2011). Transport costs and distance to clinic, as well as stigma and fear of 
disclosure are common barriers towards linkage-to-HIV-care (Govindasamy et al., 
2012; Lankowski et al., 2014).  
Rwanda is a densely populated country, with an adult HIV seroprevalence rate of 3.0% 
(National Institute of Statistics of Rwanda (NISR), 2012). The prevalence is higher in 
urban (7.1%) than rural areas (2.3%) (NISR, 2012). ART is available in 93% of 
hospitals and 29% of health centres (HC) (NISR, 2008). In 2005, the Demographic and 
Health survey of Rwanda reported that around 80% of adults had not been tested for 
HIV (NISR, 2006). The Ministry of Health (MOH) therefore recommended introducing 
PITC in all its health facilities (HFs) in 2008. At the start of the study, PITC was 
already running with high uptake rates among antenatal women and tuberculosis (TB) 
patients. PITC was not practiced in out-patient departments (OPDs); HIV testing was 
only performed when out-patients presented with symptoms of HIV infection. 
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PITC has increased ART uptake in antenatal care (ANC) clinics in SSA (Hensen et al., 
2012). Fewer studies have investigated linkage-to-HIV-care among out-patients after 
PITC (Kennedy et al., 2013; Roura et al., 2013). In this study a PITC intervention was 
introduced in OPDs of six Rwandan HFs. The objective of this study was to examine 
linkage-to-HIV-care (pre-ART, eligibility for ART and start of ART) before and after 
the introduction of a PITC intervention in the OPD. As patients who attend the OPD for 
a purpose other than getting an HIV test might be less motivated to seek HIV care than 
patients specifically coming for HIV testing, we hypothesized that linkage-to-HIV-care 
at the OPD would be lower after the introduction of PITC. 
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Methods 
Setting 
The current study was part of a cluster non-randomized controlled trial that investigated 
the HIV testing uptake and acceptability of introducing a PITC intervention in OPDs of 
Rwandan HFs (Kayigamba et al., 2012; Kayigamba et al., 2014). Eight Rwandan HFs 
were purposefully selected for this trial, ensuring inclusion of urban and rural HFs and 
sufficient numbers of attendees. All these HFs had a complete range of HIV testing, 
care and treatment activities in place. All HFs had an OPD, where routine PITC was not 
yet practiced at the start of the study. HFs were located in the Musanze district in the 
North-West of Rwanda (Ruhengeri hospital, Muhoza HC, Rwaza HC and control site 
Gasiza HC) and in the Gasabo district surrounding the capital Kigali (Kibagabaga 
hospital, Kimironko HC, Kinyinya HC and control site Kabuye HC).  
This study investigated linkage-to-HIV-care before and after the introduction of a PITC 
intervention. The following stages were investigated: (1) Linkage-to-pre-ART-care (we 
studied how many patients registered at the HFs ART clinic within 90 days of HIV 
diagnosis); (2) Eligibility for ART (at the time of the study, HIV infected patients were 
eligible for ART when CD4 count was < 350 cells/mm
3
 or they were in WHO clinical 
stage 4; TB was classified as WHO stage 3 (Trac-plus, 2009)); (3) Start of ART (we 
studied how many eligible patients started ART within 90 days of HIV diagnosis). This 
study is a sub analysis of data from the OPDs and voluntary counselling and testing 
(VCT) departments of the six HFs that implemented the intervention. Data from VCT-
departments were included in order to examine whether linkage-to-HIV-care among 
out-patients differed from VCT-patients and to detect seasonal effects. Due to low 
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numbers of HIV cases in the two control HFs, these could not serve as control sites for 
the purpose of the current study and were therefore excluded (Kayigamba et al., 2012). 
Characteristics of the HFs included in this study are described in Table S1. 
The intervention 
The intervention consisted of three phases: in phase 1 (March–May 2009) PITC was not 
operational in OPDs. In phase 2 (June–November 2009) healthcare workers (HCW) 
were trained to offer PITC and provided materials, administer HIV testing, and use 
registers adapted for the study to record details of testing. In phase 3 (December 2009 – 
February 2010) PITC was fully operational in the OPDs. Patients in OPDs were 
systematically offered an HIV test on an opt-out basis. We anticipated that this new 
intervention would increase workload and responsibility for HCW; accordingly we 
provided salary top-ups to department heads and stipends to HCW.   
Data collection 
At each HF, patients who were diagnosed with HIV were referred to the ART clinic of 
that HF, with the exception of one clinic (Muhoza), from where patients were referred 
to the neighbouring Ruhengeri hospital. At the ART clinic each patient was examined 
by a physician, the WHO stage was established, and a blood sample was taken to 
measure the CD4 count. Information on patients’ subsequent linkage-to-pre-ART care 
and ART was abstracted from ART clinic registers of each HF. Information from 
patients diagnosed with HIV was abstracted from VCT, OPD and laboratory registers of 
six Rwandan HFs during 3-month periods before (March-May 2009) and after 
(December 2009-February 2010) the introduction of PITC in the OPDs of these HFs. 
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Data collection and hospital routine have been described in detail before (Kayigamba et 
al., 2012).  
Survey 
We conducted a survey in order to identify patient-reported barriers towards linkage-to-
HIV-care. We interviewed a convenience sample of patients from each HF aged 18 
years or above who were diagnosed with HIV in phase 3 and did not enrol within 90 
days. The survey was done in August 2010 at patients’ homes. For this survey, a 
questionnaire was developed that included closed questions on demographic 
characteristics of the patient, whether the patient enrolled into care at the time of the 
survey and, if so, into which HF, and a final open-ended question about his/her 
reason(s) for not enrolling into HIV care. The questions were read to patients in 
Kinyarwanda by trained interviewers. Answers were written down on the questionnaire 
form and later translated into English by a trained translator. 
Data analysis 
We used STATA software release 11 (StataCorp, College Station, TX, USA) for all 
quantitative analyses. Associations between four explanatory variables (department by 
phase, site, sex and age) and five outcomes (enrolment into pre-ART care; advanced 
WHO stage; CD4 count; ART eligibility; and start of ART) were assessed using the chi-
squared test, Fisher’s exact test or Kruskal-Wallis test, as appropriate. Multivariable 
logistic regression analyses were done to identify factors associated with non-enrolment 
into pre-ART care, advanced clinical disease stage (WHO stage 3 or 4), ART eligibility 
and not starting ART. All explanatory variables were included in multivariable models a 
priori. P values of <0.05 were considered statistically significant. Time from HIV 
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diagnosis to enrolment into pre-ART care and to start of ART, and time from CD4 
count to start of ART were examined with Kaplan-Meier graphs. 
Answers to the open-ended survey question regarding reasons for non-enrolment in pre-
ART care were read multiple times and coded by a researcher [CF] using principles of 
thematic analysis (Boyatzis, 1998). When concepts or statements were unclear, the 
meaning of words in Kinyarwanda was discussed with the translator. Codes were 
categorized into overarching themes by discussing the findings among the authors [CF, 
KM, MB and FK] and reviewing the existing literature on commonly reported barriers 
towards linkage-to-HIV-care.  
Ethics 
Ethical approval was provided by the Rwandan National Ethics Committee and the 
research ethics committee of the Academic Medical Center, Amsterdam. Permission for 
home visits and written informed consent was obtained from all patients.  
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Results 
Patients diagnosed with HIV 
In phases 1 and 3 of the study, 722 patients were diagnosed with HIV; children below 
15 years (n=23) were excluded, as were 64 patients due to missing names or codes 
(Figure 1), leaving 635 patients in the analysis. 
Most patients were female (61.7%) and the median age was 30 years (interquartile range 
[IQR] 24-38). In phase 1, 73 patients (23.5%) were diagnosed at the OPD. In phase 3, 
the number and the relative share of patients diagnosed at the OPD increased (125; 
38.5%). Between 13 to 255 persons were diagnosed at each individual site.  
Linkage-to-pre-ART-care 
Among the 635 patients, 232 (36.5%) enrolled into pre-ART care during phase 1 and 3 
combined (Figure 1). There was no significant difference in enrolment by sex or age 
(Table 1), but enrolment varied strongly by study site: Muhoza had the lowest 
enrolment (23.5%), and Rwaza the highest (55.6%; p<0.001). Among VCT-patients 
enrolment remained relatively constant during phase 1 and 3 (38.3% and 35.5% 
respectively). Enrolment among out-patients was slightly higher than among VCT-
patients during phase 1 (43.8%), but enrolment among out-patients was lower during 
phase 3 (29.6%). The difference between enrolment among out-patients in phase 1 and 
3 was significant in univariable, but not in multivariable analysis (adjusted odds ratio 
[aOR], 2.0; 95% confidence interval [CI], 1.0-4.2; p=0.051, Table 2).   
Of the 232 patients enrolled into pre-ART care, 169 (74.6%) had done so 14 days after 
HIV diagnosis, and 205 (88.4%) after 30 days (Figure 2a). Among those who enrolled, 
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the median time to enrolment was 6 days (IQR 2-15). Median time to enrolment in 
phase 1 was 3.5 days (IQR 1-13.5) among VCT-patients, and 9 days (IQR 4.5-20.5) 
among out-patients. This was similar in phase 3 (4 days [IQR 2-10] and 9 days [IQR 4-
19] respectively).  
ART eligibility 
Of the 232 patients enrolled in pre-ART care, WHO staging was available for 217 
(93.5%) of patients. Of these, 19.8% were in WHO stage 3 and none were in stage 4 
(Table 1). This was similar for men and women (20.9% and 19.1% respectively). Only 
study site was significantly associated with high WHO stage in univariable and 
multivariable analysis (Table S2).  
CD4 count was available for 218 patients (94.0%). Median CD4 count was 384 
cells/mm
3
 (IQR, 214-539; Table 1). CD4 counts were significantly lower among men 
and older patients (p=0.003 and p=0.011 respectively). Among out-patients, the median 
CD4 count was 287 cells/mm
3
 in phase 1 and 312 cells/mm
3
 in phase 3 and among 
VCT-patients, the median CD4 count was 398 cells/mm
3
 in phase 1 and 431 cells/mm
3
 
in phase 3 (p=0.008). CD4 counts did not differ significantly between sites (Table 1). 
Both CD4 count and WHO staging was available for 89.7% (208/232) of patients. Of 
these, 93 (44.7%) were eligible for ART (Table 1). ART eligibility was fully dependent 
on a low CD4 count (<350 cells/mm
3
) as none of the patients were classified in WHO 
stage 4. Only sex was significantly associated with ART eligibility (p=0.017), with men 
being more often eligible for ART than women (aOR 1.9; 95% CI 1.0-3.5; Table S3).  
Start of ART 
12 
 
Not_for_review_Manuscript_Franse_Linkage_to_HIV_care_4juli2016.doc 
Of the 93 patients eligible for ART, 48 (51.6%) started ART within 90 days of HIV 
diagnosis (Figure 1). Among the 48 patients who started ART the median time between 
HIV diagnosis and start of ART was 35.5 days (IQR, 17-60), and between CD4 count 
and start of ART 27 days (IQR, 12.5-50) (Figure 2b&2c). The proportions of patients 
starting ART varied significantly by study site (Table 1; Table S4). Due to small 
numbers, we did not perform multivariable analysis.  
Survey results 
In total, 60 patients (34 VCT-patients and 26 out-patients) -who had not been enrolled 
into pre-ART care in phase 3 of the study- were interviewed for the survey (76% of the 
approached patients). Main reason for non-interview was that the patient had moved or 
could not be found at the provided address at the time of interview.  
The majority of patients 57% (34/60) were still not enrolled into pre-ART care (Table 
3). Of the patients who did enrol, most (10/60, 17%) enrolled at a different HF then the 
one they were tested at, and only 2/60 (3%) enrolled at the same HF. A large proportion 
of patients (14/60, 23%) were already enrolled into pre-ART care before they took an 
HIV test (a retest) in phase 3. Among VCT-patients 29% (10/34) had retested for HIV 
and among out-patients 15% (4/26) had retested for HIV (Table 3). VCT-patients had 
retested for HIV on their own initiative. Some patients that were already taking ART 
mentioned taking a retest to assess whether they had been cured by prayers. Out-patients 
had been retested on request by the HCW at the OPD. 
A reason for not enrolling into HIV care that was often reported was not accepting or 
mistrusting one’s positive HIV status (7/34, 21%). Some patients mentioned taking up 
to three or four tests at different facilities to confirm the results. Patients often reported 
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that they did not want to return to the same clinic after an HIV diagnosis, because of 
fear of being seen and stigmatized by people they knew (8/34, 24%). Some of the 
patients that reported this reason had enrolled at a different HF. Many patients (8/34, 
24%) reported that they did not enrol into HIV care because they encountered problems 
at the HF (Table 3). Specific reasons given were: long waiting times, not being told, or 
not realising, that they had to return for a follow-up, or failing to find the HCW at the 
given follow-up appointment. Some patients (5/34, 15%) mentioned that after an initial  
positive result they were tested at a different HF and had a negative HIV outcome there.  
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Discussion 
In this study in six Rwandan HFs, timely linkage-to-pre-ART-care and ART was 
suboptimal before and after the introduction of PITC. We found that enrolment among 
out-patients was lower after the implementation of PITC, although this finding was not 
significant in multivariable analysis.  
 
It is possible that under PITC, healthier out-patients enrolled less often. As 
hypothesized, when coming to the OPD for a different reason than to be tested for HIV, 
some patients might be less ready to enrol into HIV care; this may be especially the case 
for patients without clear symptoms of HIV. Low perceived susceptibility to HIV has 
been linked to treatment avoidance (Varni et al., 2012; Nakigozi et al., 2013). This 
hypothesis is supported by the finding that out-patients in this study that enrolled into 
pre-ART care had lower absolute CD4 counts than VCT-patients both before and after 
the introduction of PITC. Several studies report that operational problems such as 
increased waiting times are common under PITC (Roura et al., 2013; Topp et al., 2010; 
Evans & Ndirangu, 2009). This could also have led to lower linkage-to-pre-ART-care 
after PITC in this study. Problems with health services were one of the main barriers 
towards linkage-to-care reported by patients in this study. Higher workload and longer 
consultation time under PITC were reported by heath staff, as previously discussed 
(Kayigamba et al., 2014).  
 
However, our findings should be interpreted with caution. The proportion of patients 
enrolling into pre-ART care in this study, both at the VCT and OPD department before 
as well as after the introduction of PITC, was among the lowest reported in SSA 
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(Kranzer et al., 2012; Rosen & Fox, 2011; Mutimura et al., 2014). Our survey among 
patients that were not registered at the ART clinic demonstrated that this proportion was 
an underestimate of patients actually linked to pre-ART care. This survey showed that 
over one-third of these non-registered patients had in fact enrolled at a different HF or, 
perhaps surprisingly, had already enrolled in HIV care prior to their diagnosis in this 
study. It is likely that these factors may have also led to underestimates of patients 
linking to pre-ART care in other studies from SSA, as in many places no tracking 
system is operational to track patients after an HIV diagnosis (Rosen & Fox, 2011; 
Bassett et al., 2010).  
 
Retesting for HIV appears to happen frequently, among non-enrolled patients and 
patients already enrolled into HIV care. Under PITC a previous HIV diagnosis and 
enrolment in care might not be communicated to the HCW. Different research by our 
group (Kayigamba et al., 2012; Kayigamba et al., 2014) found that before the 
introduction of PITC the most common reason for testing was the desire to know one’s 
HIV status, while afterwards this was because one was offered a test. Some patients 
reported an HIV negative test after their initial positive test when they were tested at a 
different facility. False positive rapid-test results have been reported in the literature 
(Gray et al., 2007; Anzala et al., 2008; Kagulire et al., 2011; Klarkowski et al., 2009), 
but operational issues, such as non-observance of standard operating procedures and 
lack of quality control might also play a role (Shanks et al., 2013). 
 
Our findings should be viewed in the wider context of a strong present HIV/AIDS 
stigma. Difficulty in accepting their test result and fear of being seen at the HF were 
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main barriers towards enrolment in pre-ART care mentioned by patients in this study 
and also resulted in them repeating HIV testing. Other studies have reported that denial 
of HIV status and fear of HIV stigma can result in non-engagement in care and 
decreased quality of life (Kamen et al., 2012; Weaver et al., 2004; Nakigozi et al., 2013; 
Beer et al., 2009).  
 
This study was subject to certain limitations. Missing or non-matching data between HF 
registers (names, age, sex, initial department of consultation) resulted in the exclusion 
of 9% of patients. The survey was held among a relatively small sample of patients from 
phase 3. We were unable to explore differences in reported barriers before and after the 
introduction of PITC and the power to find significant differences between VCT and 
OPD departments was limited. A key strength of our study is that we used routine data 
from primary care clinics and hospitals, reflecting routine healthcare practice. Another 
strength is that we triangulated our findings from the hospital registers with data from a 
survey among non-enrolled patients, through which we were able to explore patient-
reported barriers towards linkage-to-HIV-care.  
 
In conclusion, the introduction of PITC in the OPD may have had a negative impact on 
linkage-to-HIV-care in Rwandan HFs. Healthier patients tested through PITC might be 
less ready to engage in HIV care. Fear of HIV stigma and mistrust of test results appear 
to be at the root of these problems.  
 
17 
 
Not_for_review_Manuscript_Franse_Linkage_to_HIV_care_4juli2016.doc 
Captions 
Figure 1. Flow of linkage-to-pre-ART-care and start of ART among HIV infected 
patients, Rwanda, March – May 2009 (phase 1) and December 2009 – February 2010 
(phase 3).  
ART= antiretroviral treatment; WHO=World Health Organization. 
 
Figure 2. a. Time to enrolment at ART clinic among 635 HIV patients from date of HIV 
diagnosis. b. Time to start ART among 93 eligible HIV patients, from date of HIV 
diagnosis. c. Time to start ART among 93 eligible HIV patients, from date of CD4 
count. Rwanda, March – May 2009 (phase 1) and December 2009 – February 2010 
(phase 3). 
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Table 1: Linkage to pre-ART care, WHO stage, CD4 count, ART eligibility, and start of ART, by department of test, study phase, study site, sex 
and age; Rwanda, March - May 2009 (phase 1) and December 2009 - February 2010 (phase 3). 
 Total 
Number (%) of patients 
enrolled into pre-ART 
care ≤ 90 days 
Number (%) of 
patients in 
WHO stage 3/4a 
Median CD4 
count in 
cells/mm3 (IQR) b 
Number (%) of 
ART-eligible 
patients c 
Number (%) of eligible 
patients that started 
ART ≤ 90 days 
Total 635 232/635 (36.5) 43/217 (19.8) 384 (214-539) 93/208 (44.7) 48/93 (51.6) 
 Department, by phase       
OPD phase 1 73 32/73 (43.8) 7/28 (25.0) 287 (112-387) 16/27 (59.3) 11/16 (68.8) 
OPD phase 3 125 37/125 (29.6) 7/37 (18.9) 312 (134-563) 19/35 (54.3) 10/19 (52.6) 
VCT phase 1 237 92/237 (38.3) 12/85 (14.1) 398 (288-533) 30/81 (37.0) 16/30 (53.3) 
VCT phase 3 200 71/200 (35.5) 17/67 (25.4) 431 (245-655) 28/65 (43.1) 11/28 (39.3) 
P-valued  0.180 0.317 0.008 0.132 0.304 
Study site       
Muhoza 255 60/255 (23.5) 17/60 (28.3) 391 (260-560) 28/60 (46.7) 22/28 (78.6) 
Ruhengeri 13 6/13 (46.2) 3/6 (50.0) 177 (97-440) 4/6 (66.7) 3/4 (75.0) 
Kibagabaga 90 35/90 (38.9) 1/27 (3.7) 444 (262-568) 8/27 (29.6) 8/8 (100.0) 
Kinyinya 92 38/92 (41.3) 9/37 (24.3) 367 (276-702) 15/31 (48.4) 5/15 (33.3) 
Kimironko 158 78/158 (49.4) 10/72 (13.9) 358 (154-533) 32/69 (46.4) 5/32 (15.6) 
Rwaza 27 15/27 (55.6) 3/15 (20.0) 369 (215-408) 6/15 (40.0) 5/6 (83.3) 
P-valued  <0.001 0.017 0.306 0.537 <0.001 
Sex       
Male 243 92/243 (37.9) 18/86 (20.9) 311 (154-484) 45/82 (54.9) 27/46 (58.7) 
Female 392 140/392 (35.7) 25/131 (19.1) 422 (269-605) 48/126 (38.1) 21/47 (44.7) 
P-valued  0.585 0.739 0.003 0.017 0.176 
Age group       
15-24 years 160 58/160 (36.3) 9/55 (16.4) 487 (288-660) 18/53 (34.0) 7/18 (38.9) 
25-34 years 254 92/254 (36.2) 14/84 (16.7) 385 (222-582) 36/81 (44.4) 18/36 (50.0) 
35-44 years 122 44/122 (36.1) 10/42 (23.8) 317 (109-435) 22/39 (56.4) 10/22 (45.5) 
≥45 years 90 38/90 (42.2) 10/36 (27.8) 360 (215-453) 17/35 (48.6) 13/17 (76.5) 
P-valued  0.753 0.415 0.011 0.183 0.125 
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Those aged <15 were excluded from the analyses.  ART antiretroviral treatment; HIV Human immunodeficiency virus;   IQR interquartile range; 
OPD Outpatient department; VCT Voluntary counselling and testing; WHO World Health Organization. 
a. WHO stage was available for 217/232.  
b. CD4 count results were available for 218/232.  
c. ART eligibility was based on CD4 count (CD4<350 cells/mm3) and WHO stage (stage 4), which were available for 208/232 patients  
d. The P-values are based on Chi-squared test, Fisher’s exact test or Kruskal-Wallis test, as appropriate. 
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Table 2. Factors associated with non-enrolment among adult HIV patients diagnosed in VCT or 
OPD department of six Rwanda health facilities, March-May 2009 (phase 1) and December 2009- 
February 2010 (phase 3); univariable and multivariable logistic regression.  
 
 n/N (%) OR (95% CI) P-value aOR (95% CI) P-value 
Total  403/635 (63.5)     
Phase   0.177  0.061 
OPD phase 1 41/73 (56.2) 1  1  
OPD phase 3 88/125 (70.4) 1.9 (1.0-3.4)  2.0 (1.0-4.2)  
VCT phase 1 145/237 (61.2) 1.2 (0.7-2.1)  1.1 (0.6-2.1)  
VCT phase 3 129/200 (64.5) 1.4 (0.8-2.4)  1.3 (0.6-2.5)  
      
Site   <0.001  <0.001 
Muhoza 195/255 (76.5) 1  1  
Ruhengeri 7/13 (53.9) 0.4 (0.1-1.1)  0.3 (0.1-0.9)  
Kibagabaga 55/90 (61.1) 0.5 (0.3-0.8)  0.5 (0.3-0.8)  
Kinyinya 54/92 (58.7) 0.4 (0.3-0.7)  0.4 (0.2-0.7)  
Kimironko 80/158 (50.6) 0.3 (0.2-0.5)  0.3 (0.2-0.4)  
Rwaza 12/27 (44.4) 0.2 (0.1-0.6)  0.3 (0.1-0.7)  
      
Sex   0.586  0.813 
Female 252/392 (64.3) 1  1  
Male 151/243 (62.1) 0.9 (0.7-1.3)  1.0 (0.7-1.5)  
      
Age     0.756  0.678 
15-24 years 102/160 (63.8) 1.3 (0.7-2.3)  1.3 (0.7-2.3)  
25-34 years 162/254 (63.8) 1.3 (0.8-2.1)  1.3 (0.8-2.2)  
35-44 years 78/122 (63.9) 1.3 (0.7-2.3)  1.4 (0.8-2.6)  
≥45 years 52/90 (57.8) 1  1  
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Those aged <15 years were excluded from the analyses. aOR adjusted odds ratio; HIV Human 
Immunodefiency Virus; OPD Outpatient department; VCT Voluntary counselling and testing; OR 
odds ratio; 95% CI 95% confidence interval. 
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Table 3. Characteristics of 60 survey respondents who were not enrolled into pre-ART care in phase 3 of the study, their enrolment 
status at the time of the survey and reason(s) for non-enrolment, Rwanda, August 2010. 
 All patients 
N = 60 
VCT-patients 
N = 34 
Out-patients  
N = 26 
P valuea 
Median age (IQR) 32 (25-40) 30 (25-40) 37 (25-45) 0.379 
Sex  N (%) N (%) N (%) 0.362 
Male 26 (43) 13 (38) 13 (50)  
Female 34 (57) 21 (62) 13 (50)  
Education    0.609 
None 10 (17) 5 (15) 5 (19)  
Primary  39 (65) 24 (71) 15 (58)  
Secondary 10 (17) 5 (15) 5 (19)  
Vocational training 1 (2) 0 (0) 1 (4)  
Site    <0.001 
Muhoza 27 (45) 20 (59) 7 (27)  
Ruhengeri 5 (8) 0 (0) 5 (19)  
Kibagabaga 5 (8) 0 (0) 5 (19)  
Kinyinya 10 (17) 8 (24) 2 (8)  
Kimironko 9 (15) 4 (12) 5 (19)  
Rwaza 4 (7) 2 (6) 2 (8)  
Enrolled into pre-ART care at time of survey    0.644 
Yes, before they took the HIV (re)test in phase 3 14 (23) 10 (29) 4 (15)  
Yes, at a different health facility  10 (17) 5 (15) 5 (19)  
Yes, at the same health facility  2 (3) 1 (3) 1 (4)  
No 34 (57) 18 (53) 16 (62)  
Reason(s) for not enrolling into pre-ART careb  N=34 N=18 N=16 0.485 
Due to problems with the service at the health facility  8 (24) 6 (33) 2 (13)  
Fear of the consequences of disclosing HIV status  8 (24) 2 (11) 6 (38)  
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Difficulties accepting or mistrusting the test result 7 (21) 4 (22) 3 (19)  
Negative HIV test at different health facility  5 (15) 4 (22) 1 (6)  
No time to come back to the clinic  4 (12) 1 (6) 3 (19)  
Feeling healthy, do not see the need  4 (12) 2 (11)  2 (13)  
Believe that prayers can cure HIV  3 (9) 2 (11) 1 (6)  
Not seeing the benefit of taking ART 3 (9) 2 (11) 1 (6)  
Otherc 4 (12) 3 (17) 1 (6)  
ART antiretroviral treatment; HIV Human immunodeficiency virus;   IQR interquartile range; VCT Voluntary counselling and testing. 
a. The P-values are based on Chi-squared test, Fisher’s exact test or Kruskal-Wallis test, as appropriate. 
b. More reasons per person could be given 
c. The other 4 reasons given were: due to a misunderstanding with the husband; lacking the willingness; lost health insurance card; 
too old to act upon the problem. 
